MDT

$88.44

Post-MarketAs of Mar 17, 8:00 PM UTC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$88.44
Potential Downside
19.5%
Whystock Fair Value$71.16
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable car...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$113.55B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
24.70
Beta
Defensive asset. Lower volatility than the S&P 500.
0.73
Div Yield
Strong income play. Yield provides a meaningful total return floor.
322.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
9.39%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.55

Recent News

Motley Fool
Mar 17, 2026

Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure

You don't have to go all in to profit from AI.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
24/7 Wall St.
Mar 16, 2026

NVIDIA Rises as CEO Jensen Huang Takes the Stage at GTC Event

NVIDIA (NASDAQ:NVDA) stock rallied as much as 4% today, with shares touching $188 before pulling back but still closing firmly in the green. The move came as CEO Jensen Huang took the stage at the company’s annual GTC developer conference in San Jose, California. GTC runs March 16 through 19, and Huang’s keynote has historically been ... NVIDIA Rises as CEO Jensen Huang Takes the Stage at GTC Event

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MedTech Dive
Mar 16, 2026

Vicarious Surgical applies for Nasdaq listing

The robotics company reduced its 2026 cash burn forecast and said its development timeline remains on track, with a system design freeze expected by year-end.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 15, 2026

Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?

HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 15, 2026

Citi Lifts PT on Johnson & Johnson (JNJ) to $274 From $250 – Here’s Why

Johnson & Johnson (NYSE:JNJ) is one of the most profitable blue chip stocks to invest in now. On March 11, Citi lifted the price target on Johnson & Johnson (NYSE:JNJ) to $274 from $250 while maintaining a Buy rating on the shares. The firm told investors in a research note that it adjusted price targets […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.